Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from cidara therapeutics Mundipharma currently has commercial rights to rezafungin outside the u.s This provides mundipharma with global ownership of rezafungin including ongoing development and distribution
Kaitlin Witcher / kaitlinwitcher / piddleass Nude OnlyFans Photo #238
1 invasive candidiasis, is a severe, life.
Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate rezzayo (rezafungin) from cidara therapeutics, including ongoing development and distribution
The assets and rights will be acquired by napp pharmaceutical group, which is a member of the international network of mundipharma independent associated companies. This provides mundipharma with global ownership of rezafungin including ongoing development and distribution.